Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation-Reference-Cited by-同舟云学术

Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

Published:2006-02-06 Issue:7 Volume:103 Page:2190-2195
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:PNAS

Author:

Burd Craig J.,Petre Christin E.,Morey Lisa M.,Wang Ying,Revelo Monica P.,Haiman Christopher A.,Lu Shan,Fenoglio-Preiser Cecilia M.,Li Jiwen,Knudsen Erik S.,Wong Jiemin,Knudsen Karen E.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference44 articles.

1. A history of prostate cancer treatment

2. The development of androgen-independent prostate cancer

3. The Androgen Receptor in Prostate Cancer

4. FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer;2024-03-30

2. D-Type Cyclins in Development and Disease;Genes;2023-07-14

3. Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation;Cell Death & Disease;2023-04-06

4. Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1‐pRB‐E2F1 pathway;Journal of Cellular and Molecular Medicine;2023-03-13

5. The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer;Nature Structural & Molecular Biology;2022-11